September 15, 2021 Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz.
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat
September 14, 2021 Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
September 13, 2021 C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON,
September 1, 2021 Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field C-Path, NORD and FDA have spent two years building the platform set to launchSept. 14 at the 2021 RDCA-DAP Workshop. TUCSON, Ariz.
August 25, 2021 WEBINAR | Alternative Solutions in Safety Assessment When: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
August 23, 2021 ePRO Consortium Welcomes Medable C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Compr
August 18, 2021 C-Path Selects Arizona Financial Leader, former U.S. Embassy Finance Director, as CFO TUCSON, Ariz., August 18, 2021— Critical Path Institute (C-Path) is pleased to announce that it has selected Kevin Perkins as it
August 17, 2021 View Now | C-Path Neuroscience Program Webinar – NfL in Neurodegenerative Diseases C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members,
August 17, 2021 Celebrating National Nonprofit Day and Sharing C-Path Updates As we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communitie
